SHANGHAI, China and CAMBRIDGE, Mass., May 25, 2023 Zai Lab Limited today announced that members of the company’s senior management team will participate in the following investor. | May 25, 2023
SHANGHAI, China and CAMBRIDGE, Mass., May 18, 2023 Zai Lab Limited today announced that the Center for Drug Evaluation of China’s National Medical Products Administration has granted. | May 18, 2023
Company to Host Conference Call and Webcast on May 10, 2023, at 8:00 a.m. ETSHANGHAI, China and CAMBRIDGE, Mass., April 20, 2023 Zai Lab Limited today announced that it will report financial. | April 20, 2023
New translational and clinical biomarker data from Zai Lab’s global oncology program ZL-1211 will be featured in a poster presentation SHANGHAI and CAMBRIDGE, Mass., April 11, 2023 Zai Lab. | April 11, 2023